ResMed Inc. (RMD) Return on equity 2017–2026
ResMed Inc. (RMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
23.1%FY2026 · since FY2017: 17.5% → 23.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 23.1% | -0.3 pp |
| FY2025 | 23.5% | +2.5 pp |
| FY2024 | 21.0% | -0.7 pp |
| FY2023 | 21.7% | -1.5 pp |
| FY2022 | 23.2% | +6.7 pp |
| FY2021 | 16.4% | -8.5 pp |
| FY2020 | 24.9% | +5.4 pp |
| FY2019 | 19.5% | +4.2 pp |
| FY2018 | 15.3% | -2.1 pp |
| FY2017 | 17.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice